IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 43 - 2025
10/28/2025 01:00 PM • Ipsen reported strong sales growth of 12.1% year-to-date and announced plans to acquire ImCheck Therapeutics to expand its oncology leadership, focusing on a clinical-stage program in acute myeloid leukemia.
IPSEY - Strong sales performance, strategic acquisition, and expansion of oncology pipeline indicate positive business momentum
Investing.com • Ali Merchant